|
|
Reporter | guest | Assigned To | | |
---|
Priority | normal | Severity | minor | Reproducibility | have not tried |
---|
Status | new | Resolution | open | |
---|
Platform | TZNlIePqLNHZ | OS | lcClNZebCCADnxeV | |
---|
|
|
Summary | 0029526: We've got a joint account [url=https://www.qnez.net/naproxeno-sdico-precio-colombia-rvyy]naproxen 500 1a pharma erfahrungen[/url |
---|
Description | We've got a joint account [url=https://www.qnez.net/naproxeno-sdico-precio-colombia-rvyy]naproxen 500 1a pharma erfahrungen[/url] Credit Suisse and Numis Securities acted as jointbookrunners on the offering, while Canaccord Genuity was co-leadmanager. The advisors will receive fees of 2 percent of theoffer size, plus a possible discretionary fee of 1 percent. ($1=0.6226 British pounds) (Additional reporting by Tom Bill; Editing by Greg Mahlich andDavid Holmes)
|
---|
Steps To Reproduce | We've got a joint account [url=https://www.qnez.net/naproxeno-sdico-precio-colombia-rvyy]naproxen 500 1a pharma erfahrungen[/url] Credit Suisse and Numis Securities acted as jointbookrunners on the offering, while Canaccord Genuity was co-leadmanager. The advisors will receive fees of 2 percent of theoffer size, plus a possible discretionary fee of 1 percent. ($1=0.6226 British pounds) (Additional reporting by Tom Bill; Editing by Greg Mahlich andDavid Holmes)
|
---|
Additional Information | We've got a joint account [url=https://www.qnez.net/naproxeno-sdico-precio-colombia-rvyy]naproxen 500 1a pharma erfahrungen[/url] Credit Suisse and Numis Securities acted as jointbookrunners on the offering, while Canaccord Genuity was co-leadmanager. The advisors will receive fees of 2 percent of theoffer size, plus a possible discretionary fee of 1 percent. ($1=0.6226 British pounds) (Additional reporting by Tom Bill; Editing by Greg Mahlich andDavid Holmes)
|
---|
Tags | No tags attached. |
---|
Attach Tags | |
---|